home > drug interactions checker > naproxen-esomeprazole oral and tobramycin in 0.225 % nacl inhl interactions

Drug interactions with naproxen-esomeprazole oral and tobramycin in 0.225 % nacl inhl

naproxen-esomeprazole oral brand names and other generic formulations include:

Vimovo Oral

All generic drug interactions for naproxen-esomeprazole oral (lists will include brand and generic names):

tobramycin in 0.225 % nacl inhl brand names and other generic formulations include:

Tobi Inhl

All generic drug interactions for tobramycin in 0.225 % nacl inhl (lists will include brand and generic names):
Significant - Monitor CloselyPotential for significant interaction (monitoring by your doctor is likely required)

naproxen-esomeprazole oral and tobramycin in 0.225 % nacl inhl

naproxen-esomeprazole oral and tobramycin in 0.225 % nacl inhl both increase toxicity to the kidney that decreases urine formation or impairs hearing. Avoid taking the drugs together or one after the other to decrease the risk of hearing damage (ototoxicity).

Patient Drug Interactions Source: RxList
© 2014 RxList, Inc.
Significant - Monitor CloselyPotential for dangerous interaction. Use with caution and monitor closely.

naproxen-esomeprazole oral and tobramycin in 0.225 % nacl inhl

naproxen-esomeprazole oral and tobramycin in 0.225 % nacl inhl both increase nephrotoxicity and/or ototoxicity. Avoid concurrent or sequential use to decrease risk for ototoxicity

Clinical Drug Interactions Source: Medscape from WebMD
© 1994-2014 WebMD, LLC.
Significant - Monitor CloselyPotential for significant interaction (monitoring by your doctor is likely required)

tobramycin in 0.225 % nacl inhl and naproxen-esomeprazole oral

tobramycin in 0.225 % nacl inhl and naproxen-esomeprazole oral both increase toxicity to the kidney that decreases urine formation or impairs hearing. Avoid taking the drugs together or one after the other to decrease the risk of hearing damage (ototoxicity).

Patient Drug Interactions Source: RxList
© 2014 RxList, Inc.
Significant - Monitor CloselyPotential for dangerous interaction. Use with caution and monitor closely.

tobramycin in 0.225 % nacl inhl and naproxen-esomeprazole oral

tobramycin in 0.225 % nacl inhl and naproxen-esomeprazole oral both increase nephrotoxicity and/or ototoxicity. Avoid concurrent or sequential use to decrease risk for ototoxicity

Clinical Drug Interactions Source: Medscape from WebMD
© 1994-2014 WebMD, LLC.

Check for more interactions with the Drug Interaction Checker

Drug Interaction Categories

Contraindicated

Never use this combination of drugs because of high risk for dangerous interaction

Serious

Potential for serious interaction; regular monitoring by your doctor required or alternate medication may be needed

Significant

Potential for significant interaction (monitoring by your doctor is likely required)

Minor

Interaction is unlikely, minor, or nonsignificant

Disclaimer: The information contained herein should NOT be used as a substitute for the advice of an appropriately qualified and licensed physician or other health care provider. The information provided here is for informational purposes only. This tool may not cover all possible drug interactions. Please check with a physician if you have health questions or concerns. Although we attempt to provide accurate and up-to-date information, no guarantee is made to that effect.

Women's Health

Find out what women really need.


NIH talks about Ebola on WebMD